NZ556613A - Substituted pyridine derivatives - Google Patents

Substituted pyridine derivatives

Info

Publication number
NZ556613A
NZ556613A NZ556613A NZ55661306A NZ556613A NZ 556613 A NZ556613 A NZ 556613A NZ 556613 A NZ556613 A NZ 556613A NZ 55661306 A NZ55661306 A NZ 55661306A NZ 556613 A NZ556613 A NZ 556613A
Authority
NZ
New Zealand
Prior art keywords
alk
pyridin
dimethyl
morpholin
cycloalk
Prior art date
Application number
NZ556613A
Other languages
English (en)
Inventor
Christian Wenzel Tornoe
Nikolay Khanzhin
Mario Rottlander
William Patrick Watson
Daniel Rodriguez Greve
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Priority claimed from PCT/DK2006/000123 external-priority patent/WO2006092143A1/en
Publication of NZ556613A publication Critical patent/NZ556613A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ556613A 2005-03-03 2006-03-02 Substituted pyridine derivatives NZ556613A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65842805P 2005-03-03 2005-03-03
DKPA200500321 2005-03-03
PCT/DK2006/000123 WO2006092143A1 (en) 2005-03-03 2006-03-02 Substituted pyridine derivatives

Publications (1)

Publication Number Publication Date
NZ556613A true NZ556613A (en) 2010-11-26

Family

ID=37908541

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ556613A NZ556613A (en) 2005-03-03 2006-03-02 Substituted pyridine derivatives

Country Status (14)

Country Link
KR (2) KR20130088905A (xx)
CN (3) CN101133053A (xx)
AR (1) AR052931A1 (xx)
BR (1) BRPI0608122A2 (xx)
DK (1) DK2298766T3 (xx)
EA (1) EA016244B1 (xx)
ES (1) ES2433593T3 (xx)
HK (1) HK1164868A1 (xx)
IL (1) IL185113A (xx)
NZ (1) NZ556613A (xx)
PT (1) PT2298766E (xx)
SI (1) SI2298766T1 (xx)
UA (1) UA92340C2 (xx)
ZA (1) ZA200705987B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114409593B (zh) * 2022-01-20 2024-02-23 上海泾维化工科技有限公司 一种2-氨基-5-甲基吡啶的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ516610A (en) * 1999-08-04 2004-05-28 Icagen Inc Benzanilides as potassium channel openers
CA2412208C (en) * 2000-06-29 2009-08-18 Neurosearch A/S Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
WO2002066036A1 (en) * 2001-02-20 2002-08-29 Bristol-Myers Squibb Company 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators
CA2519582A1 (en) * 2003-03-21 2004-09-30 H. Lundbeck A/S Substituted p-diaminobenzene derivatives
TWI357901B (en) * 2004-03-12 2012-02-11 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivati

Also Published As

Publication number Publication date
EA016244B1 (ru) 2012-03-30
IL185113A0 (en) 2007-12-03
AR052931A1 (es) 2007-04-11
HK1164868A1 (en) 2012-09-28
CN102276523A (zh) 2011-12-14
SI2298766T1 (sl) 2014-05-30
BRPI0608122A2 (pt) 2010-11-09
UA92340C2 (xx) 2010-10-25
CN102516165A (zh) 2012-06-27
ZA200705987B (en) 2009-05-27
IL185113A (en) 2013-10-31
PT2298766E (pt) 2013-11-07
EA200701877A1 (ru) 2008-02-28
CN102276523B (zh) 2014-12-10
KR20130088905A (ko) 2013-08-08
DK2298766T3 (da) 2013-11-11
CN101133053A (zh) 2008-02-27
KR20070108884A (ko) 2007-11-13
ES2433593T3 (es) 2013-12-11

Similar Documents

Publication Publication Date Title
AU2006220130B2 (en) Substituted pyridine derivatives
US8299075B2 (en) Substituted thiomorpholine derivatives
NZ556613A (en) Substituted pyridine derivatives
MXPA06010329A (en) Substituted morpholine and thiomorpholine derivatives

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 02 MAR 2016 BY CPA GLOBAL

Effective date: 20130117

LAPS Patent lapsed